查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
体外受精市场- 2018-2028年全球行业规模、份额、趋势、机会和预测，按技术、产品、卵子捐赠者、不孕不育、不孕不育、地区和竞争细分
市场调查报告书
商品编码
1326505

体外受精市场- 2018-2028年全球行业规模、份额、趋势、机会和预测，按技术、产品、卵子捐赠者、不孕不育、不孕不育、地区和竞争细分

In-Vitro Fertilization Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technique, By Product, By Egg Donor, By Infertility, By Infertility, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

体外受精市场在 2024 年至 2028 年的预测期内将出现令人印象深刻的增长。这一增长是由于不孕率上升、体外受精技术的进步以及推迟生育趋势的日益增长造成的。

不孕率上升

不孕率上升是预测期内体外受精（IVF）市场的主要驱动因素之一。由于一系列因素，包括生活方式的改变、生育延迟以及多囊卵巢综合征 (PCOS) 等疾病的发病率增加，不孕症在世界范围内变得越来越普遍。因此，对试管受精作为不孕不育解决方案的需求不断增长，预计这将推动试管受精市场的增长。

随着不孕率持续上升，越来越多的人开始寻求体外受精来解决生育问题。试管受精对于长期尝试怀孕但未成功或患有其他疾病而无法自然受孕的夫妇特别有用。

对 IVF 服务的需求不断增长预计将推动预测期内 IVF 市场的增长。预计这种增长在发展中国家尤其强劲，这些国家获得试管受精服务的机会有限，但对不孕不育治疗的需求很高。在这些国家，随着越来越多的人意识到体外受精的好处以及医疗保健系统变得更加先进，体外受精服务市场预计将会增长。

此外，技术的进步使体外受精变得更加容易和负担得起。例如，胚胎培养、冷冻保存和实验室技术的改进都有助于提高成功率和降低成本，使体外受精更容易为更多人群所接受。这进一步增加了对试管受精服务的需求，预计将推动预测期内试管受精市场的增长。

不孕率上升预计将成为预测期内全球体外受精市场的主要驱动力。随着越来越多的人遭受不孕不育的困扰，对体外受精服务的需求预计将会增加，特别是在获得不孕不育治疗的机会有限的发展中国家。

体外受精技术的进步

由于 IVF 技术的进步，IVF 需求有所增加。自 1978 年通过体外受精实现第一例婴儿诞生以来，已经取得了很多成就。如今，体外受精是一项高度复杂的程序，涉及多个步骤和先进技术。

IVF 技术最重要的进步之一是植入前基因检测 (PGT)。 PGT 允许在胚胎植入子宫之前对胚胎进行遗传疾病筛查。 PGT可以提高IVF的成功率，降低后代遗传性疾病的风险。

IVF 技术的另一项进步是延时成像的使用。延时成像使胚胎学家能够实时监测胚胎的发育，提供有关其活力和质量的更详细信息。

除了这些进步之外，试管受精诊所现在还提供一系列服务，包括卵子冷冻、精子库和代孕。这些服务为不孕不育的夫妇提供了更多选择，并促进了 IVF 市场的增长。

转向延迟分娩

延迟生育的转变是预测期内全球体外受精（IVF）市场增长的另一个因素。随着社会和经济因素的变化，人们选择将孩子推迟到晚年。生育延迟与年龄相关因素导致的不孕风险增加有关，例如卵巢储备功能下降和子宫内膜异位症等疾病发生率增加。

随着越来越多的人选择推迟生育，对试管婴儿服务的需求预计将会增加。对于因年龄相关因素而苦苦挣扎的夫妇来说，体外受精已成为一种可行的选择。试管受精治疗可以帮助女性使用自己的卵子受孕，即使她们的卵巢储备已经下降。这意味着超过自然生育窗口的女性可以怀孕。

此外，IVF技术的进步，包括改进的胚胎培养和冷冻保存技术，增加了使用IVF治疗成功受孕的机会。这些进步带来了更高的成功率和更低的成本，使想要怀孕的夫妇更容易获得和负担得起体外受精。

延迟分娩的转变预计将在预测期内推动 IVF 市场的增长。预计这种增长在发展中国家尤其强劲，这些国家延迟生育的趋势最为明显。在这些国家，试管受精治疗已成为因年龄相关因素而困扰不孕症的夫妇越来越受欢迎的选择。

延迟分娩的转变预计将成为预测期内全球体外受精市场的主要驱动力。随着越来越多的人推迟生育，对试管受精服务的需求预计将会增加，特别是在发达国家，这一趋势最为明显。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：服务概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球体外受精市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按技术分类（ICSI IVF 与非 ICSI/传统 IVF）
    • 按产品（IVF 培养基、ICSI 机器、IVF 培养箱、冷冻系统等）
    • 按卵子捐赠者（冷冻非捐赠者、新鲜非捐赠者、冷冻捐赠者、新鲜捐赠者）
    • 按不孕不育（男性与女性）
    • 按应用（生育诊所、医院、其他）
    • 按地区
    • 按公司划分 (2022)
  • 产品图

第 6 章：北美体外受精市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按技术
    • 按产品分类
    • 通过卵子捐赠者
    • 通过不孕不育
    • 按应用
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲体外受精市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按技术
    • 按产品分类
    • 通过卵子捐赠者
    • 通过不孕不育
    • 按应用
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章：亚太地区体外受精市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按技术
    • 按产品分类
    • 通过卵子捐赠者
    • 通过不孕不育
    • 按应用
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章：南美洲体外受精市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按技术
    • 按产品分类
    • 通过卵子捐赠者
    • 通过不孕不育
    • 按应用
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲体外受精市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按技术
    • 按产品分类
    • 通过卵子捐赠者
    • 通过不孕不育
    • 按应用
    • 按国家/地区
  • MEA：国家分析
    • 南非体外受精
    • 沙特阿拉伯体外受精
    • 阿联酋体外受精
    • 土耳其体外受精

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球体外受精市场：SWOT 分析

第 14 章：波特的五力分析

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
    • The Fertility Center of Las Vegas
    • Overlake Reproductive Health
    • Gennet City Fertility
    • Zita West Clinic
    • Fertility Plus Clinic
    • Nova IVF Centre and Fertility Clinic
    • Bloom IVF Centre
    • Progenesis Fertility Center
    • Medicana IVF Center
    • Medical Park Hospitals
    • ART Fertility Clinics
    • Millennium Medical Center (MMC) IVF Fertility Center
    • Tambre Fertility Clinic
    • Medical Park Hospitals
    • Hisar Hospital

第 16 章：战略建议

简介目录
Product Code: 15131

In-Vitro Fertilization Market will see impressive growth during the forecast period, 2024-2028. This growth is accounted for by increasing infertility rates, advancements in IVF technology, and a growing trend toward delaying childbirth.

In-vitro fertilization (IVF) is a medical procedure that involves fertilizing an egg with sperm outside the body in a laboratory dish and then transferring the embryo to the uterus. It is a widely used assisted reproductive technology (ART) that has helped millions of couples worldwide to conceive.

The infertility rate has been increasing globally. This is one of the key factors driving the growth of the IVF market. Several factors, including lifestyle changes, pollution, and an increase in age-related infertility, have contributed to the rising infertility rates.

Technological advancements in IVF have made the procedure safer, more effective, and less invasive. The use of preimplantation genetic testing (PGT) to screen embryos for genetic abnormalities, for example, has increased the success rates of IVF and reduced the risk of genetic disorders.

Medical tourism has emerged as a key driver of the IVF market in recent years. Patients from countries where IVF treatment is either expensive or unavailable are increasingly traveling to other countries to undergo treatment. This has helped to boost demand for IVF in countries with advanced IVF infrastructure and expertise.

The growing trend of fertility preservation, particularly among cancer patients, is driving demand for IVF services. As more people seek to preserve their fertility before undergoing treatments that could potentially harm their reproductive capacity, in such cases, IVF is becoming an increasingly important option.

A growing trend towards delaying childbirth has contributed to the growth of the IVF market. Women are now focusing on their careers and delaying pregnancy until later in life. This has led to a higher demand for IVF services, as women over the age of 35 are more likely to experience infertility.

However, with any rapidly growing industry, the IVF market faces challenges that could impact its long-term sustainability and success. One of the primary challenges the IVF market is facing is the cost of treatment. IVF is an expensive procedure, and even in countries with universal healthcare, access to IVF is often limited to those who can afford it. This has led to concerns about the affordability of IVF, particularly as demand for the treatment continues to rise.

Another challenge being faced by the IVF market is the ethical and moral considerations associated with the procedure. There are concerns that IVF could be used to create designer babies or that embryos may be discarded or used for research purposes without consent. As a result, there is a need for clear guidelines and regulations to ensure that IVF is used ethically and responsibly.

The procedure's high rate of multiple births will also impede market expansion in the coming years. To improve the probability of success, IVF frequently involves the transfer of numerous embryos, but this can lead to multiple pregnancies, which are linked to a higher risk of issues like early birth and low birth weight. To lower the probability of multiple births, more efficient embryo selection techniques are required.

Rising Infertility Rates

Rising infertility rates are one of the key drivers of the market for in-vitro fertilization (IVF) in the forecast period. Infertility is becoming more prevalent worldwide due to a range of factors, including changing lifestyles, delayed childbearing, and increasing incidence of conditions such as polycystic ovary syndrome (PCOS). As a result, there is a growing demand for IVF as a solution to infertility, which is expected to drive growth in the IVF market.

As infertility rates continue to rise, more people are turning to IVF as a solution to their fertility problems. IVF is particularly useful for couples who have been trying to conceive for a long time without success or who have other medical conditions that prevent them from conceiving naturally.

The rising demand for IVF services is expected to drive growth in the IVF market in the forecast period. This growth is expected to be particularly strong in developing countries, where access to IVF services is limited, but the need for infertility treatments is high. In these countries, the market for IVF services is expected to grow as more people become aware of the benefits of IVF and as healthcare systems become more advanced.

Furthermore, advancements in technology have made IVF more accessible and affordable. For example, improvements in embryo culture, cryopreservation, and laboratory techniques have all contributed to higher success rates and lower costs, making IVF more accessible to a wider population. This has further increased the demand for IVF services and is expected to drive the growth of the IVF Market in the forecast period.

Rising infertility rates are expected to be a key driver of the global market for in-vitro fertilization in the forecast period. As more people struggle with infertility, the demand for IVF services is expected to increase, particularly in developing countries where access to infertility treatments is limited.

Advancements in IVF Technology

IVF demand has increased as an outcome of advancements in IVF technology. Since the first birth made possible by IVF in 1978, much has been accomplished. Today, IVF is a highly sophisticated procedure that involves multiple steps and advanced technologies.

One of the most significant advances in IVF technology is Preimplantation Genetic Testing (PGT). PGT allows embryos to be screened for genetic disorders before they are implanted into the uterus. PGT can improve the success rates of IVF and reduce the risk of genetic disorders in offspring.

Another advancement in IVF technology is the use of time-lapse imaging. Time-lapse imaging allows embryologists to monitor the development of embryos in real time, providing more detailed information about their viability and quality.

In addition to these advances, IVF clinics are now offering a range of services, including egg freezing, sperm banking, and surrogacy. These services provide more options for couples struggling with infertility and have contributed to the growth of the IVF market.

Shift Towards Delayed Childbirth

The shift towards delayed childbirth is another factor responsible for the growth of the global market of in-vitro fertilization (IVF) in the forecast period. With changing social and economic factors, people are choosing to delay having children until later in life. This delay in childbearing has been associated with an increased risk of infertility due to age-related factors, such as decreased ovarian reserve and an increased incidence of conditions like endometriosis.

As more people choose to delay having children, the demand for IVF services is expected to increase. IVF has become a viable option for couples who are struggling with infertility due to age-related factors. IVF treatment can help women to conceive using their own eggs, even if their ovarian reserve has declined. This means that women who are past their natural fertility window can conceive.

Moreover, the advancements in IVF technology, including improved embryo culture and cryopreservation techniques, have increased the chances of successful conception using IVF treatment. These advancements have resulted in higher success rates and lower costs, making IVF more accessible and affordable for couples who are looking to conceive.

The shift towards delayed childbirth is expected to drive the growth of the IVF market in the forecast period. This growth is expected to be particularly strong in developing countries, where the trend towards delayed childbirth is most pronounced. In these countries, IVF treatment has become an increasingly popular option for couples who are struggling with infertility due to age-related factors.

The shift towards delayed childbirth is expected to be a key driver of the global market for in vitro fertilization in the forecast period. As more people delay having children, the demand for IVF services is expected to increase, particularly in developed countries where the trend is most pronounced.

Market Segmentation

Global In-Vitro Fertilization Market can be segmented based on technique, product, egg donor, infertility, application, and region. Based on technique, the market can be divided into ICSI IVF and non-ICSI/ traditional IVF. Based on product, the market is divided into IVF culture media, ICSI machines, IVF incubators, cryo-system, and others. Based on egg donors, the market is divided into frozen non-donor, fresh non-donor, frozen donors, and fresh donors. Based on infertility, the market can be divided into male and female. Based on application, the market is divided into fertility clinics, hospitals, and others. Regionally, the In-Vitro Fertilization Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

The Fertility Center of Las Vegas, Overlake Reproductive Health, Gennet City Fertility, Zita West Clinic, Fertility Plus Clinic, Nova IVF Centre and Fertility Clinic, Bloom IVF Centre, Progenesis Fertility Center, Medicana IVF Center, Medical Park Hospitals, ART Fertility Clinics, Millennium Medical Center (MMC) IVF Fertility Center, Tambre Fertility Clinic, Medical Park Hospitals, Hisar Hospital among others are the leading players operating in the Global In-Vitro Fertilization Market.

Report Scope:

In this report, Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

In-Vitro Fertilization Market, By Technique:

  • ICSI IVF
  • Non-ICSI/ Traditional IVF

In-Vitro Fertilization Market, By Product:

  • IVF Culture Media
  • ICSI Machine
  • IVF Incubators
  • Cryo-System
  • Others

In-Vitro Fertilization Market, By Egg Donor:

  • Frozen Non-donor
  • Fresh Non-donor
  • Frozen Donor
  • Fresh Donor

In-Vitro Fertilization Market, By Infertility:

  • Male
  • Female

In-Vitro Fertilization Market, By Application:

  • Fertility Clinics
  • Hospitals
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global In-Vitro Fertilization Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-Vitro Fertilization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
    • 5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
    • 5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
    • 5.2.4. By Infertility (Male v/s Female)
    • 5.2.5. By Application (Fertility Clinics, Hospitals, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Product Map

6. North America In-Vitro Fertilization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Product
    • 6.2.3. By Egg Donor
    • 6.2.4. By Infertility
    • 6.2.5. By Application
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In-Vitro Fertilization Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Egg Donor
        • 6.3.1.2.4. By Infertility
        • 6.3.1.2.5. By Application
    • 6.3.2. Canada In-Vitro Fertilization Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Egg Donor
        • 6.3.2.2.4. By Infertility
        • 6.3.2.2.5. By Application
    • 6.3.3. Mexico In-Vitro Fertilization Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Egg Donor
        • 6.3.3.2.4. By Infertility
        • 6.3.3.2.5. By Application

7. Europe In-Vitro Fertilization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Product
    • 7.2.3. By Egg Donor
    • 7.2.4. By Infertility
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France In-Vitro Fertilization Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Egg Donor
        • 7.3.1.2.4. By Infertility
        • 7.3.1.2.5. By Application
    • 7.3.2. Germany In-Vitro Fertilization Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Egg Donor
        • 7.3.2.2.4. By Infertility
        • 7.3.2.2.5. By Application
    • 7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Egg Donor
        • 7.3.3.2.4. By Infertility
        • 7.3.3.2.5. By Application
    • 7.3.4. Italy In-Vitro Fertilization Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Egg Donor
        • 7.3.4.2.4. By Infertility
        • 7.3.4.2.5. By Application
    • 7.3.5. Spain In-Vitro Fertilization Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Egg Donor
        • 7.3.5.2.4. By Infertility
        • 7.3.5.2.5. By Application

8. Asia-Pacific In-Vitro Fertilization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Product
    • 8.2.3. By Egg Donor
    • 8.2.4. By Infertility
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China In-Vitro Fertilization Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Egg Donor
        • 8.3.1.2.4. By Infertility
        • 8.3.1.2.5. By Application
    • 8.3.2. India In-Vitro Fertilization Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Egg Donor
        • 8.3.2.2.4. By Infertility
        • 8.3.2.2.5. By Application
    • 8.3.3. Japan In-Vitro Fertilization Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Egg Donor
        • 8.3.3.2.4. By Infertility
        • 8.3.3.2.5. By Application
    • 8.3.4. South Korea In-Vitro Fertilization Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Egg Donor
        • 8.3.4.2.4. By Infertility
        • 8.3.4.2.5. By Application
    • 8.3.5. Australia In-Vitro Fertilization Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Egg Donor
        • 8.3.5.2.4. By Infertility
        • 8.3.5.2.5. By Application

9. South America In-Vitro Fertilization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Product
    • 9.2.3. By Egg Donor
    • 9.2.4. By Infertility
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil In-Vitro Fertilization Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Egg Donor
        • 9.3.1.2.4. By Infertility
        • 9.3.1.2.5. By Application
    • 9.3.2. Argentina In-Vitro Fertilization Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Egg Donor
        • 9.3.2.2.4. By Infertility
        • 9.3.2.2.5. By Application
    • 9.3.3. Colombia In-Vitro Fertilization Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Egg Donor
        • 9.3.3.2.4. By Infertility
        • 9.3.3.2.5. By Application

10. Middle East and Africa In-Vitro Fertilization Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Product
    • 10.2.3. By Egg Donor
    • 10.2.4. By Infertility
    • 10.2.5. By Application
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa In-Vitro Fertilization Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Egg Donor
        • 10.3.1.2.4. By Infertility
        • 10.3.1.2.5. By Application
    • 10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Egg Donor
        • 10.3.2.2.4. By Infertility
        • 10.3.2.2.5. By Application
    • 10.3.3. UAE In-Vitro Fertilization Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Egg Donor
        • 10.3.3.2.4. By Infertility
        • 10.3.3.2.5. By Application
    • 10.3.4. Turkey In-Vitro Fertilization Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Technique
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Egg Donor
        • 10.3.4.2.4. By Infertility
        • 10.3.4.2.5. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global In-Vitro Fertilization Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
    • 15.4.1. The Fertility Center of Las Vegas
    • 15.4.2. Overlake Reproductive Health
    • 15.4.3. Gennet City Fertility
    • 15.4.4. Zita West Clinic
    • 15.4.5. Fertility Plus Clinic
    • 15.4.6. Nova IVF Centre and Fertility Clinic
    • 15.4.7. Bloom IVF Centre
    • 15.4.8. Progenesis Fertility Center
    • 15.4.9. Medicana IVF Center
    • 15.4.10. Medical Park Hospitals
    • 15.4.11. ART Fertility Clinics
    • 15.4.12. Millennium Medical Center (MMC) IVF Fertility Center
    • 15.4.13. Tambre Fertility Clinic
    • 15.4.14. Medical Park Hospitals
    • 15.4.15. Hisar Hospital

16. Strategic Recommendations